Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: Effects on subjective quality of life

Australian and New Zealand Journal of Psychiatry

Volumn 44, Issue 2, 2010, Pages 144-150

  Bechdolf, Andreas ^a,b   Knost, Brbel ^a   Nelson, Barnaby ^b   Schneider, Nicola ^a   Veith, Verena ^a   Yung, Alison R ^b   Pukrop, Ralf ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cognitive behaviour therapy; Psychotherapy; Quality of life; Schizophrenia

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PSYCHOEDUCATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHI-SQUARE DISTRIBUTION; COGNITIVE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PATIENT SATISFACTION; PSYCHOTHERAPY, GROUP; QUALITY OF LIFE; QUESTIONNAIRES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELF CARE; TREATMENT OUTCOME;

EID: 76449095089     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.3109/00048670903393571     Document Type: Article

References (41)

1. Zimmerman G, Favrod J, Trieu VH et al. The effect of cognitive behavioural treatment on the positive symptoms of schizophrenia spectrum disorders: a meta-analysis. Schizophr Res 2005; 77:1-9.
2. Jones C, Cormac I, Silveira da Mota Neto J, Campbell C. Cognitive behaviour therapy for schizophrenia. Cochrane Database Syst Rev 2004; (4):CD000524.
3. Pilling S, Bebbington P, Kuipers E et al. Psychological treatment in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychol Med 2002; 32:763-782.
4. Gould RA, Mueser KT, Bolton E, Mays V, Goff D. Cognitive therapy for psychosis in schizophrenia: an effect size analysis. Schizophr Res 2001; 48:335-342.
5. Rector NA, Beck AT. Cognitive behavioral therapy for schizophrenia: an empirical review. J Nerv Ment Dis 2001; 189: 278-287.
6. Lehman AF, Kreyenbuhl J, Buchanan RW et al. The schizophrenia patients outcomes research team (PORT): updated treatment recommendations. Schizophr Bull 2004; 30:193-217.
7. National Institute for Clinical Excellence. Schizophrenia: core interventions in the treatment and management of schizophrenia in primary and secondary care. London: The Royal College of Psychiatrists and the British psychological Society 2003. [cited 2 June 2009.] Available from URL: http://www.nice.org.uk/guidance/ index
8. German Society for Psychiatry, Psychotherapy and Neurology (DGPPN). Treatment guideline schizophrenia. Darmstadt: Steinkopf, 2006.
9. Barrowclough C, Haddock G, Lobban F et al. Group cognitivebehavioural therapy for schizophrenia. Randomized controlled trial. Br J Psychiatry 2006; 189:527-532.
10. Wykes T, Parr AM, Landlau S. Group treatment of auditory hallucinations. Exploratory study of effectiveness. Br J Psychiatry 1999; 175:180-185.
11. Wykes T, Hayward P, Thomas N et al. What are the effects of group cognitive behaviour therapy for voices? A randomised control trial. Schizophr Res 2005; 77:201-210.
12. Bechdolf A, Knost B, Kuntermann C et al. A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatr Scand 2004; 110:21-28.
13. Bechdolf A, Köhn D, Knost B, Pukrop R, Klosterkötter J. A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in patients with schizophrenia: outcomes at 24-months. Acta Psychiatr Scand 2007; 112:173-179.
14. Lawrence R, Bradshaw T, Mairs H. Group cognitive behavioural therapy for schizophrenia: a systematic review of the literature. J Psychiatr Ment Health Nurs 2006; 13:673-681.
15. Lehman AF. The well-being of chronic mental patients. Arch Gen Psychiatry 1983; 40:369-373.
16. Lehman AF, Ward NC, Linn LS. Chronic mental patients: the quality of life issue. Am J Psychiatry 1982; 139:1271-1276.
17. Pukrop R, Schlaak V, Möller-Leimkühler AM et al. Reliability and validity of quality of life assessed by the short-form 36 and the modular system for quality of life in patients with schizophrenia and patients with depression. Psychiatr Res 2003; 119:63-79.
18. Ritsner M, Modaj I, Endicott J et al. Differences in quality of life domains and psychopathologic and psychosocial factors in psychiatric patients. J Clin Psychiatry 2000; 6:880-889.
19. Wiersma D, Jenner JA, Nienhuis FJ, van de Willige G. Hallucination focused integrative treatment improves quality of life in schizophrenia patients. Acta Psychiatr Scand 2004; 109: 194-201.
20. Atkinson JM, Coia DA, Gilmour WH, Haper JP. The impact of education groups for people with schizophrenia on social functioning and quality of life. Br J Psychiatry 1996; 168:199-204.
21. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13:261-276.
22. Pukrop R, Möller HJ, Steinmeyer EM. Quality of life in psychiatry. A systematic contribution to construct validation and the development of the integrative assessment tool 'modular system of quality of life'. Eur Arch Psychiatry Clin Neurosci 2000; 250:120-132.
23. Janke W, Erdman G, Kallus W. Stress Coping Questionnaire. Goettingen: Hogrefe, 1985.
24. Krampen K. Locus of Control Questionnaire. Goettingen: Hogrefe, 1991.
25. Ware J. SF-36 health survey. Manual and interpretation guide. Boston: Health Institute, New England Medical Center, 1993.
26. Klosterkötter S, Ruhrmann S, Schultze-Lutter F. The European Prediction of Psychosis Study (EPOS): integrating early recognition and intervention in Europe. World Psychiatry 2005; 4:161-167.
27. Tarrier N, Kinney C, McCarthy E et al. Coping strategy enhancement (CSE): a method of treating residual schizophrenic symptoms. Behav Psychother 1990; 18:283-293.
28. Tarrier N, Beckett R, Harwood S et al. A trial of two cognitivebehavioural methods treating drug-resistant residual psychotic symptoms in schizophrenic patients. Br J Psychiatry 1993; 162:524-532.
29. Tarrier N, Yusupoff L, Kinney C et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. Br Med J 1998; 317:303-307.
30. Tarrier N, Wittkowski A, Kinney C et al. Durability of the effects of cognitive-behavioural therapy in the treatment of chronic schizophrenia: 12-month follow-up. Br J Psychiatry 1999; 174:500-504.
31. Tarrier N, Kinney C, McCarthy E et al. Two-year follow-up of cognitive-behavioural therapy and supportive counselling in the treatment of persistent symptoms in chronic schizophrenia. J Consult Clin Psychol 2000; 5:917-922.
32. Lewis S, Tarrier N, Haddock G et al. Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: acute-phase outcomes. Br J Psychiatry 2002; 181 (Suppl 43):91-97.
33. Tarrier N, Lewis S, Haddock G et al. Cognitive-behavioural therapy in first-episode and early schizophrenia. 18-month followup of a randomized controlled trial. Br J Psychiatry 2004; 184:231-239.
34. Barrowclough C, Haddock G, Tarrier N et al. Randomized controlled trial of motivational interviewing, cognitive behaviour therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. Am J Psychiatry 2001; 158:1706-1713.
35. Haddock G, Barrowclough C, Tarrier N et al. Cognitivebehavioural therapy and motivational intervention for schizophrenia and substance misuse. 18-month outcomes of a randomized controlled trial. Br J Psychiatry 2003; 183:418-426.
36. Hornung WP, Kieserg A, Feldmann R. Psychoeducational training for schizophrenic patients: background, procedure and empirical findings. Patient Educ Couns 1996; 29:257-268.
37. Hornung WP, Feldmann R, Klingberg S, Buchkremer G, Reker T. Long-term effects of psychoeducational psychotherapeutic intervention for schizophrenic outpatients and their key-persons: results of a five-year follow-up. Eur Arch Psychiatry Clin Neurosci 1999; 29:162-167.
38. Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003; 64:664-667.
39. Cohen J. Statistical power analysis for the behavioral sciences (rev. ed.). Hillsdale, NJ: Erlbaum, 1988.
40. Röhricht F, Priebe S. Effect of body-oriented psychological therapy on negative symptoms in schizophrenia: a randomized controlled trial. Psychol Med 2006; 36:669-678.
41. Sensky T, Turkington D, Kingdon D et al. A randomized controlled trial of cognitive-behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Arch Gen Psychiatry 2000; 57:165-172.